organization · Reporting owner
Bausch Health Companies Inc.
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Bausch & Lomb CorpBLCO · Entity 3756 | 10% owner | June 01, 2022 | June 02, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Bausch & Lomb Corp
Report date June 01, 2022 · Filed June 02, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Shares, No Par ValueSEC Table I · non-derivative | IndirectSee footnote | 310,449,643 |
Reported balance
After 2022-06-01 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2022-06-01 · Sale · Disposed 4,550,357 · Balance 310,449,643 F1: Reflects common shares, no par value ("Common Shares"), of Bausch + Lomb Corporation (the "Issuer") sold to the underwriters in connection with the underwriters' partial exercise of the overallotment option in connection with the initial public offering of the Issuer that closed on May 10, 2022 (the "Offering"). The material terms of the Offering are described in the prospectus dated May 5, 2022, filed by the Issuer with the Securities and Exchange Commission on May 6, 2022. F2: Reflects Common Shares owned directly and indirectly by the reporting person through a wholly-owned subsidiary of the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects common shares, no par value ("Common Shares"), of Bausch + Lomb Corporation (the "Issuer") sold to the underwriters in connection with the underwriters' partial exercise of the overallotment option in connection with the initial public offering of the Issuer that closed on May 10, 2022 (the "Offering"). The material terms of the Offering are described in the prospectus dated May 5, 2022, filed by the Issuer with the Securities and Exchange Commission on May 6, 2022.
F2: Reflects Common Shares owned directly and indirectly by the reporting person through a wholly-owned subsidiary of the reporting person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2022 Filed Jun 2, 2022 20:05 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | SaleCommon Shares, No Par Value | 4,550,357 | $17.06 | $77,606,338.64 |
DisclosureSEC source: 0000899243-22-020663 · doc4.xml · nonDerivative · entry 1 Bausch Health Companies Inc. · CIK 0000885590 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 310,449,643 F1 · shares: Reflects common shares, no par value ("Common Shares"), of Bausch + Lomb Corporation (the "Issuer") sold to the underwriters in connection with the underwriters' partial exercise of the overallotment option in connection with the initial public offering of the Issuer that closed on May 10, 2022 (the "Offering"). The material terms of the Offering are described in the prospectus dated May 5, 2022, filed by the Issuer with the Securities and Exchange Commission on May 6, 2022. F2 · ownership.nature: Reflects Common Shares owned directly and indirectly by the reporting person through a wholly-owned subsidiary of the reporting person. Read SEC document |
| May 10, 2022 Filed May 12, 2022 20:18 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | SaleCommon Shares, No Par Value | 35,000,000 | $17.06 | $596,925,000.00 |
DisclosureSEC source: 0000899243-22-017761 · doc4.xml · nonDerivative · entry 1 Bausch Health Companies Inc. · CIK 0000885590 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 315,000,000 F1 · shares: Reflects common shares, no par value ("Common Shares"), of Bausch + Lomb Corporation (the "Issuer") sold to the underwriters pursuant to an Underwriting Agreement, dated May 5, 2020, in connection with the initial public offering of the Issuer, which closed on May 10, 2022 (the "Offering"). The material terms of the Offering are described in the prospectus dated May 5, 2022, filed by the Issuer with the Securities and Exchange Commission on May 6, 2022. F2 · ownership.nature: Reflects Common Shares owned directly and indirectly by the reporting person through a wholly-owned subsidiary of the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.